12:00 AM
 | 
Mar 18, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Modufolin: Preliminary Phase I/II data

Preliminary data from 16 patients with colon cancer in the single-blind, Swedish Phase I/II ISO-CC-002 trial showed that 60 and 200 mg/m 2 IV bolus injections of Modufolin were safe and led to "substantially greater"...

Read the full 154 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >